Tidiacic arginine: Difference between revisions
No edit summary |
m (Protected "Tidiacic arginine": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))) |
||
(One intermediate revision by one other user not shown) | |||
Line 74: | Line 74: | ||
<!--Chemical data--> | <!--Chemical data--> | ||
}} | }} | ||
__NOTOC__ | __NOTOC__ | ||
{{SI}} | {{SI}} |
Latest revision as of 17:16, 20 August 2015
![]() | |
![]() | |
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
UNII | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C5H7NO4S |
Molar mass | 177.18 g/mol |
3D model (JSmol) | |
| |
(verify) |
Combination of | |
---|---|
Tidiacic | hepatoprotective |
Arginine | amino acid |
[[{{{component3}}}]] | ? Class |
[[{{{component4}}}]] | ? Class |
[[{{{component5}}}]] | ? Class |
Clinical data | |
Trade names | Tiadilon |
ATC code | |
Identifiers | |
CAS Number | |
ChemSpider | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
WikiDoc Resources for Tidiacic arginine |
Articles |
---|
Most recent articles on Tidiacic arginine Most cited articles on Tidiacic arginine |
Media |
Powerpoint slides on Tidiacic arginine |
Evidence Based Medicine |
Cochrane Collaboration on Tidiacic arginine |
Clinical Trials |
Ongoing Trials on Tidiacic arginine at Clinical Trials.gov Trial results on Tidiacic arginine Clinical Trials on Tidiacic arginine at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Tidiacic arginine NICE Guidance on Tidiacic arginine
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Tidiacic arginine Discussion groups on Tidiacic arginine Patient Handouts on Tidiacic arginine Directions to Hospitals Treating Tidiacic arginine Risk calculators and risk factors for Tidiacic arginine
|
Healthcare Provider Resources |
Causes & Risk Factors for Tidiacic arginine |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Tidiacic is a hepatoprotective drug. It is a component of tidiacic arginine.
Tidiacic arginine (trade name Tiadilon) is a 1:1 combination of the amino acid arginine and tidiacic (thiazolidine-2,4-dicarboxylic acid), which acts as a sulfur donor.
In France, its indications and use have been described as "identical to those of silymarin".[1]
References
- ↑ Laure, Patrick; Caroline Bislinger (2003). "Les produits détournés: A05. Médicaments hépatobiliaires". Les médicaments détournés (in French). Elsevier Masson. p. 169. ISBN 978-2-294-00859-7. Retrieved on January 6, 2009 through Google Book Search.
Further reading
- Rizzo S (1986). "Clinical trial with arginine tidiacicate in symptomatic chronic persistent hepatitis". Int J Clin Pharmacol Res. 6 (3): 225–30. PMID 3527997.
- Pages with script errors
- CS1 maint: Unrecognized language
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Drugs missing an ATC code
- Drugs with no legal status
- Infobox drug articles with non-default infobox title
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- Drugs that are a combination of chemicals
- Drug
- Dicarboxylic acids